Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever

<div>(a) Region-wise population coverage of the selected T cell epitopes shows 100% population coverage worldwide and in selected regions of the world. (b) Country-wise population coverage of the selected T cell epitopes shows 100% population coverage for the 110 countries among all the countries where data was available.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever 

Figure 2 | Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever 